Behaviour of Red Blood Cell Potassium and of Other Hydro-Electrolyte Parameters During Spironalactone Treatment in Patients with Non Compensated Liver Cirrhosis

  • Arnaldo Di Sciacca
  • F. Durante
  • R. M. Di Piazza
  • G. Cuccbiara
  • A. Frontini
  • A. Ingrassia
  • Giuseppe Sangiorgi Barbagallo
Chapter
Part of the Developments in Nephrology book series (DINE, volume 18)

Abstract

The purpose of this research was to stress the importance of the treatment of water-salt decompensation in the cirrhotic patient with antagonists of aldosterone and in particular of spironolactone.

Keywords

Dehydration Aldosterone Spironolactone Antialdosterone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Astrup J., Thomsen A. C., Westrup M.: Red cell sodium and potassium contents in liver cirrhosis. Gastrenterology 78, 530–534, 1980.Google Scholar
  2. 2.
    Barbagallo Sangiorgi G., Di Sciacca A., Pardo A.: Potassium depletion in aged patients: an evaluation through red-cell potassium determination. Age and Ageing 8, 190–195, 1980.Google Scholar
  3. 3.
    Barbagallo Sangiorgi G., Di Sciacca A., Fradà G. jr., Cupidi G., Barbagallo M.: Il dan-no jatrogenico da farmaci in geriatria. Nuovo Boll. Farmacol. Clinica, Napoli, 1981, 3, 157–168.Google Scholar
  4. 4.
    Barbagallo Sangiorgi G., Fradà G. jr., Di Sciacca A., Cupidi G., Affronti M., Costanza G., Putignano E., Barbagallo M.: Turbe del ricambio idroelettrico come causa di encefalopatia metabolica nell’anziano. Giorn. Geront. 30, 199–202, 1982.Google Scholar
  5. 5.
    Barbagallo Sangiorgi G., Di Sciacca A., Durante F., Fradà G. jr., Costanza G., Cupidi G.: La terapia diuretica e la terapia antiipertensiva nell’anziano. Giorn. Geront. 30, 749–774, 1982.Google Scholar
  6. 6.
    Black D.A.K.: Potassium metabolism. In: Clinical Disorders of Fluid and Electrolyte Metabolism, 2nd ed. M.H. Maxwell, C.R. Kleeman (eds.). New York, McGraw-Hill, 1972, pp. 121–149.Google Scholar
  7. 7.
    Greemblatt D.J., Koch-Weser J.: Adverse reactions to spironolactone. Jama 225, 40–43; 1973.CrossRefGoogle Scholar
  8. 8.
    Hochs H.R., Greemblatt D.J., Bodeng: Spironolactone. Am. Heart J. 90, 389, 1978.Google Scholar
  9. 9.
    Ibsen: Red blood cell potassium as a measure of body potassium. Scand. J. Clin. Lab. Invest. 34, 161–165, 1974.PubMedCrossRefGoogle Scholar
  10. 10.
    Soler N.G., Jain S., James H., Paton A.: Potassium status of patients with cirrhosis. Gut 17, 152–157, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Arnaldo Di Sciacca
    • 1
  • F. Durante
  • R. M. Di Piazza
  • G. Cuccbiara
  • A. Frontini
  • A. Ingrassia
  • Giuseppe Sangiorgi Barbagallo
    • 2
  1. 1.Institute of Internal Medicine and GeriatricsPalermoItaly
  2. 2.Systematic Medical TherapyPalermoItaly

Personalised recommendations